IN2014CH02034A - - Google Patents

Info

Publication number
IN2014CH02034A
IN2014CH02034A IN2034CH2014A IN2014CH02034A IN 2014CH02034 A IN2014CH02034 A IN 2014CH02034A IN 2034CH2014 A IN2034CH2014 A IN 2034CH2014A IN 2014CH02034 A IN2014CH02034 A IN 2014CH02034A
Authority
IN
India
Prior art keywords
crosslinked gelatin
support
active substance
physiologically active
retained
Prior art date
Application number
Other languages
English (en)
Inventor
Shinji Sugawara
Chieko Miura
Tomoko Sudo
Masao Nakagawa
Toshiyuki Yoshikawa
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2013089142A external-priority patent/JP2014210756A/ja
Priority claimed from JP2013089143A external-priority patent/JP2014210757A/ja
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Publication of IN2014CH02034A publication Critical patent/IN2014CH02034A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Laminated Bodies (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
IN2034CH2014 2013-04-22 2014-04-21 IN2014CH02034A (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013089142A JP2014210756A (ja) 2013-04-22 2013-04-22 架橋ゼラチン担体およびそれを用いた生理活性物質徐放担体
JP2013089143A JP2014210757A (ja) 2013-04-22 2013-04-22 架橋ゼラチン担体およびそれを用いた生理活性物質徐放担体

Publications (1)

Publication Number Publication Date
IN2014CH02034A true IN2014CH02034A (https=) 2015-07-03

Family

ID=50489016

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2034CH2014 IN2014CH02034A (https=) 2013-04-22 2014-04-21

Country Status (9)

Country Link
US (1) US9351934B2 (https=)
EP (1) EP2796127A1 (https=)
KR (1) KR20140126264A (https=)
CN (1) CN104109252A (https=)
AU (1) AU2014202182A1 (https=)
CA (1) CA2849472A1 (https=)
IN (1) IN2014CH02034A (https=)
RU (1) RU2014115991A (https=)
TW (1) TW201517920A (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11207258B2 (en) 2016-01-25 2021-12-28 Suntory Holdings Limited Capsule containing functional substance and method for manufacturing said capsule
CN110876812A (zh) * 2019-12-06 2020-03-13 赛克赛斯生物科技股份有限公司 明胶海绵栓塞剂及其制备方法和应用、治疗血管疾病或肿瘤的药物
CN111269444A (zh) * 2020-01-22 2020-06-12 苏州新丝原生物科技有限公司 一种交联微球及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003203A1 (fr) 1996-07-19 1998-01-29 Yamanouchi Pharmaceutical Co., Ltd. Particules poreuses insolubles dans l'eau, constituees de substances biocompatibles et leur procede de production
DE60229399D1 (de) 2001-07-18 2008-11-27 Medgel Corp Hgf-hydrogel-zubereitungen mit verzögerter freisetzung
JP2004115413A (ja) * 2002-09-25 2004-04-15 Yasuhiko Tabata 冠状動脈狭窄または閉塞治療用徐放性製剤
US20110229580A1 (en) 2010-03-22 2011-09-22 Indian Institute of Technology Bombay, School of Biosciences and Bioengineering Compositions and methods for nano-in-micro particles

Also Published As

Publication number Publication date
RU2014115991A (ru) 2015-10-27
US9351934B2 (en) 2016-05-31
KR20140126264A (ko) 2014-10-30
CN104109252A (zh) 2014-10-22
AU2014202182A1 (en) 2014-11-06
CA2849472A1 (en) 2014-10-22
US20140316013A1 (en) 2014-10-23
EP2796127A1 (en) 2014-10-29
TW201517920A (zh) 2015-05-16

Similar Documents

Publication Publication Date Title
PH12019501931A1 (en) Anti-pdl1 antibody formulations
EP3273079A4 (en) Electromagnetically enabled active type dynamic gas bearing
TWD179056S (zh) 充電器
EP3218467A4 (en) Bio-engineered hyper-functional "super" helicases
WO2014138429A3 (en) Peptidomimetic macrocycles and use thereof in regulating hif1alpha
PH12019500176B1 (en) Heterocyclic compounds and ther uses
WO2014165090A8 (en) Compounds for the treatment of tuberculosis
MX2016005395A (es) Formulacion estable de insulina glulisina.
MX2016004945A (es) Procesos para la preparacion de compuestos plaguicidas.
FR24C1005I1 (fr) Agent antitumoral et promoteur de l'effet antitumoral
MX2016014622A (es) Sistemas de suministro de medicamentos y metodos de uso relacionados.
MX365403B (es) Peptidos y metodos para usarlos.
TWD165710S (zh) 電連接器
TN2013000373A1 (en) Pharmaceutical formulation comprising inositol
TWD180565S (zh) 塗抹器
SG10201902499VA (en) Therapeutic nanoparticles and related compositions, methods and systems
IN2014CH02034A (https=)
EP2989056A4 (en) Nanoiron suspension, process for the preparation thereof its use and device for the preparation of nanoiron suspension
EP3035917A4 (en) Biologically active synthetic nanoparticle constructs and methods of use therof
EP3906931A3 (en) Use of immune suppressive domains as medicaments
MY181226A (en) Formulation of metaxalone
EP2962691A4 (en) AGENT FOR THE PREVENTION OR TREATMENT OF DISEASES OF THE POSTERIOR PART OF THE IL CONTAINING A TETRAHYDROPYRANYLAMINOCYCLOPENTYLCARBONYLTETRAHYDROPYRIDOPYRIDINE DERIVATIVE AS ACTIVE INGREDIENT
WO2015077334A3 (en) Therapies for left ventricular non-compaction and dilated cardiomyopathy
EP3305267A4 (en) Fifth generation fu's needle
IL232582B (en) Active dummy body with active pyrotechnic composition